By improving glycemic control, the medication reduces the risk of complications associated with high blood sugar
The interventions on GLP-1, whether the drug treatment or the KD of its receptor, impacted body weight, food intake, and glycemic status, which is in line with the role of GLP-1 as a dual treatment of obesity and diabetes (48)
Arch Toxicol Suppl 3:95110 10
Summary Keywords anti-inflammatory mechanisms, bioavailability, colonic metabolites, gut microbiota, interindividual variability Citation Yu H, Ning M, Long B, Ren M, Wang C, Wang Y, Chen H, Chen D, Jiang N and Liu C (2026) (-)-Epicatechin and inflammation: Unraveling the role of microbial metabolites and interindividual metabolic variability